• Endocannabinoid system dysfunction in mood and related disorders
• Antidepressant-Like and Anxiolytic-Like Effects of CBD
• The endocannabinoid system and the treatment of mood and anxiety disorders  
• Endocannabinoid signaling in the etiology and treatment of major depressive illness
• Antidepressant-like effects of cannabidiol in mice: Possible involvement of 5-HT1A receptors
• Putative role of endocannabinoid signaling in the etiology of depression and actions of antidepressants  
• Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa
• Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress 
• Serum contents of endocannabinoids are correlated with blood pressure in depressed women
• The therapeutic potential of the endocannabinoid system for the development of a novel class of antidepressants
• Antidepressants and Changes in Concentration of Endocannabinoids and N-Acylethanolamines in Rat Brain Structures
• Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT/glutamate neurotransmission: role of 5-HT1A receptors
• Prohedonic Effect of CBD in a Rat Model of Depression